C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

In a recent review published in the Microorganisms Journal, researchers reviewed existing data on the use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria, ...

Bathing daily with with chlorhexidine gluconate can reduce incidence of some hospital-acquired infections, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, ...

Scientists have discovered how the hospital superbug C.diff rapidly evolves resistance to the frontline drug used for treatment in the UK. Scientists have discovered how the hospital superbug C.diff ...

Enterococci, while part of a normal healthy microbiome, can also be significant human pathogens with an increasing role in Healthcare Associated Infection (HAI). They are major contributors to ...

Theresa Wagner has studied enterococci and antibiotic resistance for several years. Here she is photographed in connection with another research project on enterococci. Creating new vaccines is one of ...

Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in ...

Scientists have discovered how the hospital superbug C.diff rapidly evolves resistance to the frontline drug used for treatment in the UK. Clostridioides difficile (C. diff), a type of bacteria which ...

Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial resistance, which the ...